Search
Descriptor English: Muscle Relaxants, Central
Descriptor Spanish: Relajantes Musculares Centrales
Descriptor relajantes musculares centrales
Entry term(s) relajantes musculares de acción central
Scope note: Grupo heterogéneo de fármacos utilizados para producir relajación muscular, exceptuando los bloqueantes neuromusculares. Sus indicaciones clínicas y terapéuticas principales son el tratamiento de los espasmos musculares y de la inmovilidad asociada a las distensiones, torceduras y lesiones de la espalda y, en menor grado, de las lesiones cervicales. También se han utilizado para tratar distintos cuadros clínicos que solo tienen en común la presencia de hiperactividad de los músculos esqueléticos, como los espasmos musculares que pueden producirse en la ESCLEROSIS MÚLTIPLE. (Smith and Reynard, Textbook of Pharmacology, 1991, p358)
Descriptor Portuguese: Relaxantes Musculares Centrais
Descriptor French: Myorelaxants à action centrale
Entry term(s): Central Muscle Relaxants
Centrally Acting Muscle Relaxants
Relaxants, Central Muscle
Tree number(s): D27.505.696.510
D27.505.696.663.700.600
D27.505.954.427.525
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D009125
Scope note: A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)
Annotation: refers to skeletal muscle relaxants only: smooth muscle relaxants = PARASYMPATHOLYTICS
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Muscles (1966-1969)
Public MeSH Note: 70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69
Online Note: search MUSCLE RELAXANTS under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 & MUSCLES 1966-69
History Note: 70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69
Related: Parasympatholytics MeSH
DeCS ID: 9315
Unique ID: D009125
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1970/01/01
Date of Entry: 1999/01/01
Revision Date: 2007/07/09
Muscle Relaxants, Central - Preferred
Concept UI M0014240
Scope note A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)
Preferred term Muscle Relaxants, Central
Entry term(s) Central Muscle Relaxants
Centrally Acting Muscle Relaxants
Relaxants, Central Muscle



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey